Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier-Kohler, Carmen Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Kammertöns, Thomas Dr. (4) Kopp, Joachim Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Willimsky, Gerald Dr. (6) Wolf, Jana Prof. Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (20) (-) Selbach, Matthias Prof. Dr. (4) Biologie maligner Lymphome (2) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Mathematische Modellierung zellulärer Prozesse (1) (-) Molekulare Immunologie und Gentherapie (20) (-) Proteom Dynamik (4) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) (-) 1997 (9) 1998 (9) 1999 (4) 2000 (8) 2001 (8) 2002 (8) 2003 (10) 2004 (10) 2005 (14) 2006 (3) 2007 (6) 2008 (8) 2009 (8) 2010 (10) 2011 (12) 2012 (10) (-) 2013 (15) 2014 (15) 2015 (13) 2016 (12) 2017 (12) 2018 (10) 2019 (11) 2020 (6) 2021 (16) 2022 (16) 2023 (9) 2024 (2) 24 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Selbach, Matthias Prof. Dr.Molekulare Immunologie und Gentherapie Proteom Dynamik19972013 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky 05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein 01. Mai 2013 / Mol Cell Proteomics Argonaute2 regulates the pancreatic β-cell secretome S.G. Tattikota M.D. Sury T. Rathjen H.H. Wessels A.K. Pandey X. You C. Becker W. Chen M. Selbach M.N. Poy 01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein 01. Mai 2013 / Canc Res Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens J Zhang L Chen X Liu T. Kammertoens T. Blankenstein Z. Qin 15. April 2013 / Canc Cell It's the peptide-MHC affinity, stupid T. Kammertoens T. Blankenstein 01. Juli 2013 / BioEssays Synthesis and degradation jointly determine the responsiveness of the cellular proteome B. Schwanhäusser J. Wolf M. Selbach D. Busse 01. August 2013 / Canc Res Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T cell transplantation R. Hess Michelini T. Manzo T. Sturmheit V. Basso M. Rocchi M. Freschi J.J. Listopad T. Blankenstein M. Bellone A. Mondino Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
01. Mai 2013 / Mol Cell Proteomics Argonaute2 regulates the pancreatic β-cell secretome S.G. Tattikota M.D. Sury T. Rathjen H.H. Wessels A.K. Pandey X. You C. Becker W. Chen M. Selbach M.N. Poy
01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
01. Mai 2013 / Canc Res Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens J Zhang L Chen X Liu T. Kammertoens T. Blankenstein Z. Qin
01. Juli 2013 / BioEssays Synthesis and degradation jointly determine the responsiveness of the cellular proteome B. Schwanhäusser J. Wolf M. Selbach D. Busse
01. August 2013 / Canc Res Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T cell transplantation R. Hess Michelini T. Manzo T. Sturmheit V. Basso M. Rocchi M. Freschi J.J. Listopad T. Blankenstein M. Bellone A. Mondino